Djibouti
Malaria risk—predominantly due to P. falciparum—exists throughout the year in the whole country. Chloroquine-resistant P. falciparum reported.

Dominican Republic
Low malaria risk—exclusively due to P. falciparum—exists throughout the year, especially in rural areas of the western provinces such as Castañuelas, Hondo Valle and Pepillo Salcedo. There is no evidence of P. falciparum resistance to any antimalarial drug.

Ecuador
Malaria risk—P. falciparum (34%), P. vivax (66%)—exists throughout the year below 1500 m, with some risk in Cotopaxi, Loja and Los Rios. Higher transmission risk is found in El Oro, Esmeraldas and Manabi. There is no risk in Guayaquil or Quito. A high proportion of P. falciparum cases in Esmeraldas Province are reportedly resistant to chloroquine.

Egypt
Very limited P. falciparum and P. vivax malaria risk exists from June through October in El Faiyûm governorate (no cases reported since 1998).

El Salvador
Very low malaria risk—almost exclusively due to P. vivax—exists throughout the year in Santa Ana Province, in rural areas of migratory influence from Guatemala.

Equatorial Guinea
Malaria risk—predominantly due to P. falciparum—exists throughout the year in the whole country. Resistance to chloroquine and sulfadoxine–pyrimethamine reported.

Eritrea
Malaria risk—predominantly due to P. falciparum—exists throughout the year in the whole country below 2200 m. There is no risk in Asmara. Resistance to chloroquine and sulfadoxine-pyrimethanine reported.

Ethiopia
Malaria risk—predominantly due to P. falciparum—exists throughout the year in the whole country below 2000 m. Chloroquine-resistant P. falciparum reported. There is no malaria risk in Addis Ababa.

French Guiana
Malaria risk—P. falciparum (83%), P. vivax (17%)—is high throughout the year in nine municipalities of the territory bordering Brazil (Oiapoque river valley) and Suriname (Maroni river valley). In the other 13 municipalities transmission risk is low or negligible. Multidrug-resistant P. falciparum reported in areas influenced by Brazilian migration.

Gabon
Malaria risk—predominantly due to P. falciparum—exists throughout the year in the whole country. Resistance to chloroquine and sulfadoxine–pyrimethamine reported.

Gambia
Malaria risk—predominantly due to P. falciparum—exists throughout the year in the whole country. Resistance to chloroquine and sulfadoxine–pyrimethamine reported.

Georgia
Malaria risk—exclusively due to P. vivax—exists focally from July to October in some villages located in the south-eastern part of the country.

Ghana
Malaria risk—predominantly due to P. falciparum—exists throughout the year in the whole country. Resistance to chloroquine and sulfadoxine–pyrimethamine reported.

Guatemala
Malaria risk—predominantly due to P. vivax—exists throughout the year below 1500 m. There is high risk in the departments of Alta Verapaz, Baja Verapaz, Petén and San Marcos, and moderate risk in the departments of Escuintla, Huehuetenango, Izabal, Quiché, Retalhuleu, Suchitepéquez and Zacapa.

Guinea
Malaria risk—predominantly due to P. falciparum—exists throughout the year in the whole country. Resistance to chloroquine reported.

Guinea-Bissau
Malaria risk—predominantly due to P. falciparum—exists throughout the year in the whole country. Resistance to chloroquine reported.

Guyana
Malaria risk—P. falciparum (47%), P. vivax (53%)—is high throughout the year in all parts of the interior. Sporadic cases of malaria have been reported from the densely populated coastal belt. Chloroquine-resistant P. falciparum reported.

A - B | C | D - G | H - L | M - O | P - S | T - Z | Return to the country list

World Health Organization. International Travel and Health 2003. Geneva, Switzerland.